GBA1 Parkinson's Disease Research Catalyst Program
Supports the GBA1 Parkinson's Disease Research Catalyst Program, funding studies of GBA1-linked mechanisms and disease modifiers for future treatment progress.
The GBA1 Parkinson's Disease Research Catalyst Program sits under the Michael J. Fox Foundation for Parkinson's Research and funds work on GBA1-associated Parkinson's disease. Its focus is on molecular mechanisms linking GBA1 dysfunction to neurodegeneration, disease modifiers, progression factors, and cell-type or systems-level effects. Awards are up to $300,000 for 12 to 24 months, and the program is open globally. The deadline is July 22, 2026, at 5 p.m. US ET, with MJFF open-science requirements applying to data sharing and publication. Eligibility is not spelled out on the page, so applicants are expected to review the full RFA and application template before applying. The strongest proposals are the ones that connect cohorts or reuse existing resources to answer a focused biological question. That makes this a good fit for teams already working in PD genetics, mechanism, or translational biology, especially where cross-cohort integration can sharpen the readout. The program is built for relatively compact, high-clarity projects rather than open-ended exploratory work.
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.